Actavis’ Brent Saunders And Paul Bisaro Talk Innovation Vs. Discovery
This article was originally published in The Pink Sheet Daily
Executive Summary
Incoming CEO and executive chairman of the Actavis/Forest colossus discuss the end of “me-too” drugs and the future of R&D in an interview with “The Pink Sheet” DAILY.